Scholars@Duke
Megan Elizabeth Bowles Clowse

Megan Elizabeth Bowles Clowse

Professor of Medicine
Medicine, Rheumatology and Immunology
Duke Box 3535, Durham, NC 27710
Baker House 07, Duke South, Trent Drive, Durham, NC 27710

Scholarly Works - Conferences

A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

Conference Lupus · August 1, 2026 Background/Purpose: Mycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ... Full text Cite

Pregnancy Outcomes in Patients With Interstitial Lung Disease.

Conference Arthritis Care Res (Hoboken) · May 2023 OBJECTIVE: Women with interstitial lung disease (ILD) are recommended to avoid pregnancy based on limited data. This study seeks to determine maternal and pregnancy outcomes in the largest-to-date cohort of patients with ILD. METHODS: Medical records in th ... Full text Link to item Cite

Association of Hurried Communication and Low Patient Self-Efficacy With Persistent Nonadherence to Lupus Medications.

Conference Arthritis Care Res (Hoboken) · January 2023 OBJECTIVE: Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented racial minorities have disproportionately lower rates of medication adherence and more severe SL ... Full text Link to item Cite

COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.

Conference J Rheumatol · January 2022 OBJECTIVE: To describe coronavirus disease 2019 (COVID-19) and pregnancy outcomes in patients with rheumatic disease who were pregnant at the time of infection. METHODS: Since March 2020, the COVID-19 Global Rheumatology Alliance has collected cases of pat ... Full text Link to item Cite

Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Conference Arthritis Care Res (Hoboken) · March 2019 OBJECTIVE: While increased rheumatic disease activity during pregnancy has been associated with adverse pregnancy outcomes, this disease activity is typically assessed by physicians. Little is known, however, about the association between patient-reported ... Full text Link to item Cite

A Comparison of RADAI5 and RAPID3 Disease Measures

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

Pregnancy Outcomes Among Women with Rare Autoimmune Diseases

Conference ARTHRITIS & RHEUMATOLOGY · September 1, 2018 Link to item Cite

The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices.

Conference Rheumatology (Oxford) · July 1, 2018 OBJECTIVE: To survey an international sample of providers to determine their current practices for the prevention, screening, and treatment of congenital heart block (CHB) due to maternal Ro/SSA antibodies. METHODS: A survey was designed by the organizing ... Full text Link to item Cite

Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.

Conference Ann Rheum Dis · June 2018 OBJECTIVE: Prior studies found conflicting results about whether lupus is likely to flare during or after pregnancy. Using a large cohort of pregnant and non-pregnant women with lupus, we estimated the effect of pregnancy on disease flares in systemic lupu ... Full text Link to item Cite

SAT0119 Pregnancy outcomes in women with and without rheumatoid arthritis

Conference Annals of the Rheumatic Diseases · June 2017 Full text Cite

Case Study: Lupus in Pregnancy

Conference BIRTH DEFECTS RESEARCH · May 15, 2017 Link to item Cite

Infertility in Women with Rheumatoid Arthritis

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

Contraceptive Methods in Women with Rheumatoid Arthritis

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2016 Link to item Cite

AB0284 Reproductive Health in Adult Women with JIA and RA

Conference Annals of the Rheumatic Diseases · June 2016 Full text Cite

Racial Disparities in Lupus Pregnancy

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2015 Link to item Cite

A Comparison of Pregnancy Outcomes before and after Lupus Diagnosis

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2015 Link to item Cite

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.

Conference Arthritis Rheumatol · July 2015 OBJECTIVE: Vitamin D modulates the immune response and blocks induction of an interferon (IFN) signature by systemic lupus erythematosus (SLE) sera. This study was undertaken to investigate the effects of vitamin D supplementation on the IFN signature in p ... Full text Link to item Cite

The Impact Of Menopause In Rheumatoid Arthritis Activity.

Conference ARTHRITIS AND RHEUMATISM · October 1, 2013 Link to item Cite

Infertility Among Patients with Vasculitis

Conference ARTHRITIS AND RHEUMATISM · October 1, 2011 Link to item Cite

Pregnancy in Men and Women with Vasculitis

Conference ARTHRITIS AND RHEUMATISM · October 1, 2011 Link to item Cite

Contraception Use in Women with Rheumatoid Arthritis.

Conference ARTHRITIS AND RHEUMATISM · October 1, 2011 Link to item Cite

Risk factors for pregnancy loss in women with lupus

Conference Journal of Reproductive Immunology · October 2006 Full text Cite

National study of medical complications in SLE pregnancies.

Conference ARTHRITIS AND RHEUMATISM · September 1, 2006 Link to item Cite

Azathioprine use in lupus pregnancy.

Conference ARTHRITIS AND RHEUMATISM · September 1, 2005 Link to item Cite

Early risk factors for pregnancy loss in lupus

Conference OBSTETRICS AND GYNECOLOGY · April 1, 2005 Link to item Cite